title: 1α,25(OH)2D3 differentially regulates miRNA expression in human bladder cancer cells.
abstract: Bladder cancer is the fourth most commonly diagnosed cancer in men and eighth leading cause of cancer-related death in the US. Epidemiological and experimental studies strongly suggest a role for 1α,25(OH)2D3 in cancer prevention and treatment. The antitumor activities of 1α,25(OH)2D3 are mediated by the induction of cell cycle arrest, apoptosis, differentiation and the inhibition of angiogenesis and metastasis. miRNAs play important regulatory roles in cancer development and progression. However, the role of 1α,25(OH)2D3 in the regulation of miRNA expression and the potential impact in bladder cancer has not been investigated. Therefore, we studied 1α,25(OH)2D3-regulated miRNA expression profiles in human bladder cancer cell line 253J and the highly tumorigenic and metastatic derivative line 253J-BV by miRNA qPCR panels. 253J and 253J-BV cells express endogenous vitamin D receptor (VDR), which can be further induced by 1α,25(OH)2D3. VDR target gene 24-hydroxylase was induced by 1α,25(OH)2D3 in both cell lines, indicating functional 1α,25(OH)2D3 signaling. The miRNA qPCR panel assay results showed that 253J and 253J-BV cells have distinct miRNA expression profiles. Further, 1α,25(OH)2D3 differentially regulated miRNA expression profiles in 253J and 253J-BV cells in a dynamic manner. Pathway analysis of the miRNA target genes revealed distinct patterns of contribution to the molecular functions and biological processes in the two cell lines. In conclusion, 1α,25(OH)2D3 differentially regulates the expression of miRNAs, which may contribute to distinct biological functions, in human bladder 253J and 253J-BV cells. This article is part of a Special Issue entitled '17th Vitamin D Workshop'.
authors.affiliation: Department of Pharmacology and Therapeutics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: yingyu.ma@roswellpark.org.
authors.forename: Yingyu
authors.initials: Y
authors.lastname: Ma
authors.affiliation: Department of Cancer Genetics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: qiang.hu@roswellpark.org.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Hu
authors.affiliation: Department of Pharmacology and Therapeutics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: wei.luo@roswellpark.org.
authors.forename: Wei
authors.initials: W
authors.lastname: Luo
authors.affiliation: Department of Pharmacology and Therapeutics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: rachel.pratt@roswellpark.org.
authors.forename: Rachel N
authors.initials: RN
authors.lastname: Pratt
authors.affiliation: Department of Cancer Genetics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: sean.glenn@roswellpark.org.
authors.forename: Sean T
authors.initials: ST
authors.lastname: Glenn
authors.affiliation: Department of Biostatistics and Bioinformatics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: song.liu@roswellpark.org.
authors.forename: Song
authors.initials: S
authors.lastname: Liu
authors.affiliation: Department of Medicine, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: donald.trump@roswellpark.org.
authors.forename: Donald L
authors.initials: DL
authors.lastname: Trump
authors.affiliation: Department of Pharmacology and Therapeutics, Elm and Carlton Streets, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. Electronic address: candace.johnson@roswellpark.org.
authors.forename: Candace S
authors.initials: CS
authors.lastname: Johnson
mesh_terms: D002117:Calcitriol / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D014407:Tumor Cells, Cultured; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D014815:Vitamins / Q000494:pharmacology*
chemical_list: D035683:MicroRNAs; D014815:Vitamins; D002117:Calcitriol
keywords: 1α,25(OH)(2)D(3); Bladder cancer; Vitamin D; miRNA